The Toronto Stock Exchange reports that Else Nutrition Holdings Inc. will be listed and posted for trading on the TSX at the open on Jan. 25, 2022. According to the TSX, there will be 104,196,220 common shares, 4,505,150 common share purchase warrants (the 2020 warrants) and 4,024,999 common share purchase warrants (the 2021 warrants) of the company issued and outstanding, and 59,111,391 shares reserved for issuance. The shares will trade under the symbol BABY and with Cusip No. 290257 10 4, the 2020 warrants will trade under the symbol BABY.WT and with Cusip No. 290257 11 2, and the 2021 warrants will trade under the symbol BABY.WT.A and with Cusip No. 290257 12 0.
The TSX reports that Else Nutrition, through its principal subsidiary, Else Nutrition GH Ltd., is an Israel-based food and nutrition company focused
on developing innovative, clean and plant-based food and
nutrition products for infants, toddlers, children and adults. The company does not expect to pay cash dividends on its shares in the foreseeable future. The transfer agent and registrar for the company's shares is Computershare Investor Services Inc. at its principal offices in
Vancouver and Toronto, and
the transfer agent and registrar for its warrants is Computershare Trust Company of Canada
at its principal offices in Vancouver. The company's fiscal year-end is Dec. 31.
According to the TSX, Else Nutrition's shares have been listed on the TSX Venture Exchange since June 18, 2019, and its 2020 and 2021 warrants have been listed on the TSX-V since Oct. 8, 2020, and Oct. 27, 2021, respectively. As stated in the warrant indenture dated Oct. 6, 2020, the 2020 warrants are exercisable at $3.25 per share until 4 p.m. Vancouver time on Oct. 6, 2022. As stated in the warrant indenture dated Oct. 20, 2021, the 2021 warrants are exercisable at $2.70 per share until 4 p.m. Vancouver time on Oct. 20, 2026. Else Nutrition's shares, 2020 warrants and 2021 warrants will be delisted from the TSX-V on Jan. 25, 2022, upon the start of trading on the TSX.
© 2024 Canjex Publishing Ltd. All rights reserved.